AUSAFAustralis Capital Inc.

About Australis Capital Inc. (AUSAF)

Australis Capital Inc. (AUSAF) is a Drug Manufacturers - Specialty & Generic company headquartered in Las Vegas, NV, United States whose shares trade over-the-counter on the Expert Market tier.

AUSA is implementing a capital light growth strategy towards establishing a highly competitive and profitable MSO in the U.S. and global cannabis markets. AUSA's business and assets include investments in Cocoon, Body and Mind Inc., Quality Green, Folium Biosciences, and land assets in Washington. AUSA is currently working towards the closing of a transaction whereby it will acquire 100% of the membership interests in Green Therapeutics LLC, an award-winning MSO with operations in Nevada, Missouri and Oklahoma. Furthermore, the Company is working towards completing the acquisition of ALPS, the world's premier design, construction management, commissioning and post commissioning consultancy company for horticultural crops, such as cannabis, fruits, vegetables, mushrooms and algae. Through GT and ALPS, the Company believes it will be able to secure low-cost access to cannabis biomass to fuel the scale up of its award-winning brands across the U.S. and global cannabis markets.

Products and services

The Company is involved in the cannabis and horticultural industries in the United States and abroad. As a multi-state operator in the cannabis industry in the US, the Company is focused on strong brands and attractive cannabis licenses in states with favorable economics. As an engineering consulting firm, the Company advises on large scale greenhouse design, build and operations throughout the world in cannabis and horticulture.

AUSAF key facts

Ticker symbol

AUSAF

Market tier

Expert Market

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Las Vegas, NV, United States

Country of incorporation

CA

Year of incorporation

2015

Employees

16

Estimated market cap

$76.3K (as of Apr 15, 2025)

Shares outstanding

254,217,661

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

3/31

Latest filing

Interim Financial Report (Dec 31, 2021)

Australis Capital Inc. leadership

• Terrence Booth — CEO
• Roger Sykes — COO
• Jon Paul — CFO
• Adam Szweras — Corporate Secretary
• Lou Kiara Marcos — VP, Ops.

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with A